Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 125
Single User License Price INR 8750
Corporate User License Price USD 375
Corporate User License Price INR 26250
Site License Price USD 250
Site License Price INR 17500
Request a Quote

Report Title

Juno Therapeutics Inc - Strategic SWOT Analysis Review

Quote Request for License Type
License Type Price  
Single User License USD 125
Site License USD 250
Enterprise Wide License USD 375
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Juno Therapeutics Inc - Strategic SWOT Analysis Review


Quote Request for License Type
License Type Price  
Single User License USD 125
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Juno Therapeutics Inc - Strategic SWOT Analysis Review

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Juno Therapeutics Inc - Strategic SWOT Analysis Review



Executive Summary

Juno Therapeutics Inc-Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-GlobalData's summarization of the company's business strategy.

- SWOT analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list of key locations and subsidiaries of the company, including contact details.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

Highlights

Juno Therapeutics Inc (Juno) is a clinical-stage company that develops novel cellular immunotherapies. The company formulates cell-based cancer immunotherapies based on platforms such as chimeric antigen receptor and high-affinity T cell receptor technologies to genetically engineer T cells to identify and kill cancer cells. It develops CD19 CAR and WT-1 TCR clinical programs which include numerous product candidates in clinical development for several hematologic malignancies in adults and children. Juno offers CAR and TCR product candidates targeting multiple cancer types. The company is evaluating its pipeline candidates for the treatment of relapsed/refractory (r/r) Chronic Lymphocytic Leukemia (CLL), r/r B-Cell Non-Hodgkin's Lymphoma (NHL); r/r Acute Lymphoid Leukemia (ALL). It works in collaboration with various cancer centers. Juno is headquartered in Seattle, Washington, the US.

Juno Therapeutics Inc Key Recent Developments

Jan 12,2018: Juno Therapeutics Investigation By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Juno Therapeutics, Inc.-JUNO

Jan 05,2018: Juno Therapeutics Names Cindy Elkins as Chief Information Officer

Dec 20,2017: Juno Therapeutics and Thermo Fisher Scientific Announce CAR T Manufacturing Partnership

Nov 27,2017: Juno Therapeutics Appoints Ann L. Lee as Executive Vice President of Technical Operations and Patrick Y. Yang as Executive Vice President, Senior Advisor to the CEO

Nov 01,2017: Juno Therapeutics Reports Third Quarter 2017 Financial Results

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

- Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

- Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Juno Therapeutics Inc-Key Facts 5

Juno Therapeutics Inc-Key Employees 6

Juno Therapeutics Inc-Key Employee Biographies 7

Juno Therapeutics Inc-Major Products and Services 8

Juno Therapeutics Inc-History 9

Juno Therapeutics Inc-Company Statement 11

Juno Therapeutics Inc-Locations And Subsidiaries 14

Head Office 14

Other Locations & Subsidiaries 14

Joint Venture 14

Section 2-Company Analysis 15

Company Overview 15

Juno Therapeutics Inc-Business Description 16

R&D Overview 16

Juno Therapeutics Inc-SWOT Analysis 17

SWOT Analysis-Overview 17

Juno Therapeutics Inc-Strengths 17

Juno Therapeutics Inc-Weaknesses 18

Juno Therapeutics Inc-Opportunities 19

Juno Therapeutics Inc-Threats 20

Juno Therapeutics Inc-Key Competitors 21

Section 3-Company's Lifesciences Financial Deals and Alliances 22

Juno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 22

Juno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 23

Juno Therapeutics Inc, Recent Deals Summary 24

Section 4-Company's Recent Developments 25

Jan 12, 2018: Juno Therapeutics Investigation By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Juno Therapeutics, Inc.-JUNO 25

Jan 05, 2018: Juno Therapeutics Names Cindy Elkins as Chief Information Officer 26

Dec 20, 2017: Juno Therapeutics and Thermo Fisher Scientific Announce CAR T Manufacturing Partnership 27

Nov 27, 2017: Juno Therapeutics Appoints Ann L. Lee as Executive Vice President of Technical Operations and Patrick Y. Yang as Executive Vice President, Senior Advisor to the CEO 28

Nov 01, 2017: Juno Therapeutics Reports Third Quarter 2017 Financial Results 29

Oct 12, 2017: Biomarkers May Help Identify Patients at Increased Risk of Neurotoxicity From CD19 CAR T-cell Therapy 32

Oct 11, 2017: New insights into CAR T-cell therapy's potential side effects 33

Sep 21, 2017: Juno Therapeutics Opens New Headquarters and Research Center 35

Aug 09, 2017: Editas Medicine Achieves Milestone Under Juno Therapeutics Collaboration for Technical Progress Towards Overcoming the Tumor Microenvironment 36

Aug 03, 2017: Juno Therapeutics Reports Second Quarter 2017 Financial Results 37

Section 5-Appendix 39

Methodology 39

About GlobalData 39

Contact Us 39

Disclaimer 39

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Juno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 22

Juno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 23

List of Tables

Juno Therapeutics Inc, Key Facts 5

Juno Therapeutics Inc, Key Employees 6

Juno Therapeutics Inc, Key Employee Biographies 7

Juno Therapeutics Inc, Major Products and Services 8

Juno Therapeutics Inc, History 9

Juno Therapeutics Inc, Subsidiaries 14

Juno Therapeutics Inc, Joint Venture 14

Juno Therapeutics Inc, Key Competitors 21

Juno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 22

Juno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 23

Juno Therapeutics Inc, Recent Deals Summary 24

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Tragara Pharmaceuticals Inc

Novartis Pharmaceuticals Corp

NeoGenomics Inc

ImmuneXcite Inc

Eiger BioPharmaceuticals Inc

Juno Therapeutics Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Overview, Key Manufacturing Facilities, Key Information, Overview, Business Description, Major Products and Services, Brands, History, Key Employees, Key Employee Biographies, Key Operational Heads, Locations And Subsidiaries, Competitors, Company Statement.


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person